A detailed history of Nisa Investment Advisors, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 5,441 shares of DVAX stock, worth $70,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,441
Previous 3,762 44.63%
Holding current value
$70,188
Previous $42,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$10.05 - $11.61 $16,873 - $19,493
1,679 Added 44.63%
5,441 $60,000
Q2 2024

Jul 19, 2024

BUY
$10.73 - $12.58 $375 - $440
35 Added 0.94%
3,762 $42,000
Q1 2024

May 01, 2024

BUY
$11.7 - $14.98 $1,368 - $1,752
117 Added 3.24%
3,727 $46,000
Q2 2023

Aug 11, 2023

BUY
$9.85 - $13.17 $216 - $289
22 Added 0.61%
3,610 $46,000
Q1 2023

May 02, 2023

SELL
$9.44 - $11.88 $3.29 Million - $4.13 Million
-348,000 Reduced 98.98%
3,588 $35,000
Q4 2022

Feb 02, 2023

BUY
$10.27 - $13.29 $3.57 Million - $4.62 Million
348,000 Added 9699.0%
351,588 $3.74 Million
Q3 2022

Nov 07, 2022

BUY
$9.93 - $17.44 $873 - $1,534
88 Added 2.51%
3,588 $41,000
Q2 2022

Aug 03, 2022

SELL
$7.45 - $12.83 $9,312 - $16,037
-1,250 Reduced 26.32%
3,500 $44,000
Q1 2022

Apr 29, 2022

SELL
$9.75 - $14.44 $5,070 - $7,508
-520 Reduced 9.87%
4,750 $51,000
Q4 2021

Feb 03, 2022

SELL
$13.17 - $20.94 $79,020 - $125,640
-6,000 Reduced 53.24%
5,270 $68,000
Q2 2021

Aug 06, 2021

BUY
$7.25 - $10.99 $68,875 - $104,405
9,500 Added 536.72%
11,270 $111,000
Q4 2020

Jan 25, 2021

BUY
$3.73 - $5.6 $2,051 - $3,080
550 Added 45.08%
1,770 $8,000
Q1 2020

Apr 17, 2020

BUY
$2.27 - $6.2 $1,407 - $3,844
620 Added 103.33%
1,220 $4,000
Q1 2018

Apr 10, 2018

SELL
$14.65 - $19.9 $4,395 - $5,970
-300 Reduced 33.33%
600 $12,000
Q4 2017

Jan 12, 2018

BUY
$17.3 - $24.08 $15,570 - $21,672
900
900 $17,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.